Announcement on Subsidiary’s TFA003 Tablets Obtaining the Notice of Approval for Drug Clinical Trials

About this update from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

Announcement on Subsidiary’s TFA003 Tablets Obtaining the Notice of Approval for Drug Clinical Trials The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Conba Pharmaceutical Co., Ltd. Class A